Introduction
A critical component of HIV treatment and prevention programs is viral suppression among HIV-positive persons. Viral suppression not only leads to improved health outcomes for the individual, but can also reduce the risk of HIV transmission [1, 2] . Given the importance of viral suppression, increasing the percentage of persons living with diagnosed HIV (PLWDH) who are virally suppressed to 80% has been set as a national goal in the United States [3] . Among PLWDH at year-end 2014 in the United States, only 57.9% were virally suppressed, and this varied by race/ethnicity, age, transmission category, and state [4] . For example, among black/African American (hereafter referred to as black) PLWDH, 51.5% were virally suppressed compared to 65.0% of white PLWDH. Among the 38 jurisdictions included in the report, the percentage virally suppressed ranged from a low of 34.3% in Virginia to a high of 78.8% in Montana. These disparities suggest a need for local interventions tailored to the population segments most in need to eliminate the disparities and achieve the national goal. To aid in this process, this analysis uses national HIV surveillance data to examine disparities at the jurisdiction level to reveal variations in the profile of disparities that may be masked at the national level. [4] . Viral suppression within 12 months of diagnosis was assessed among persons with HIV diagnosed in 2014 and who were alive for at least 12 months after diagnosis. Time to viral suppression was calculated using Kaplan-Meier survival analysis method with 12 months of observation. All analyses were restricted to persons who were 13 years or older either at diagnosis (time to viral suppression and viral suppression within 12 months of diagnosis) or at year-end 2013 (viral suppression during 2014). Area of residence for the time to viral suppression and viral suppression within 12 months of diagnosis was based on residence at HIV diagnosis; for analysis on viral suppression during 2014 among persons living with HIV, residence was based on most recent known address at the end of 2014. All analyses were stratified by jurisdiction, and viral suppression during 2014 were further stratified by age group, race/ethnicity, and transmission category, so disparities could be evaluated. To account for missing risk factor information, transmission category was adjusted using multiple imputation [5] .
Results
Overall, among PLWDH in 2014 in the 38 jurisdictions, 57.9% were virally suppressed, and, among all persons (relative difference: −42%) and Louisiana (relative difference: −38%). In general, viral suppression was higher among older age groups in all regions (Fig. 2) , although the age gradient was less pronounced in the Northeast compared to the other regions. The relative difference between the youngest and oldest age groups was 14% in the Northeast compared to approximately 20% in all other regions. The areas with the least variation in viral suppression by age group were Rhode Island, Virginia, and Wisconsin. Two areas had the opposite pattern with the youngest age group having higher viral suppression than the oldest age group; Colorado and North Dakota.
By transmission category, viral suppression was highest among males with infection attributed to male-tomale sexual contact (men who have sex with men, MSM; living with diagnosed or undiagnosed HIV, viral suppression was 47.3% (Table 1 ). Viral suppression was higher among whites (65.0%) than blacks (51.5%) or Hispanics/ Latinos (58.2%). This disparity persisted in most jurisdictions with a relative difference of 10% or higher in many areas (Fig. 1) . In three jurisdictions viral suppression was higher among blacks than whites by at least a relative difference of 5%; Wyoming (relative difference: 18%), North Dakota (relative difference: 11%), and Rhode Island (relative difference: 5%). The areas with the largest disparity between blacks and whites were West Virginia (relative difference: -37%) and South Dakota (relative difference: −31%). In one jurisdiction viral suppression was higher among Hispanics/Latinos than whites (Maryland, relative difference: 5%). The areas with the largest disparity between Hispanics/Latinos and whites were South Dakota 61.2%) and lowest among males with infection attributed to injection drug use (IDU; 48.4%; Table 2 ). The area with the highest viral suppression among MSM was Montana (80.8%) and the lowest was Virginia (34.1%). The area with the highest viral suppression among persons with infection attributed to IDU was Alaska (males: 75.4%, females: 79.7%) and the lowest among male persons who inject drugs (PWID) was Utah (26.5%) and among female PWID was South Dakota (32.8%). The area with the highest viral suppression among persons with infection attributed to male-to-male sexual contact and IDU (MSM/IDU) was North Dakota (86.0%) and the lowest was South Dakota (11.4%). The area with the highest viral suppression among persons with infection attributed to heterosexual contact was Montana (males: 85.2%, females: 79.8%) and the lowest was Virginia (males: 34.3%, females: 34.8%). In most areas, MSM had higher viral suppression than all other transmission categories with a couple notable exceptions (Fig. 3) . In Alaska, male and female PWID, MSM/IDU, and females with infection attributed to heterosexual contact all had higher viral suppression than MSM. In North Dakota, female PWID, MSM/IDU, and females with infection attributed to heterosexual contact all had higher viral suppression than MSM. In addition, females with infection attributed to heterosexual contact in Colorado (relative difference: 18%), female PWID in Rhode Island (relative difference: 14%), male PWID in Nebraska (relative difference: 11%), and MSM/IDU in Virginia (relative difference: 17%) all had higher viral suppression than MSM in the respective jurisdictions.
Among persons who received an HIV diagnosis in 2014, 68.2% were virally suppressed within 12 months of diagnosis (Table 3) . This varied by jurisdiction from a high of 92.3% in Montana to a low of 59.7% in the District of Columbia. Time to viral suppression was 6.9 months overall with a range of 4.5 months in Montana to 7.8 months in Mississippi and the District of Columbia. Six jurisdictions attained at least 80% viral suppression within 12 months of diagnosis with an average time to viral suppression under 6 months; Connecticut, Iowa, Maine, Montana, New Hampshire, and Washington.
Discussion
Overall, in our analysis of viral suppression among PLWDH at year-end 2014 in 38 jurisdictions, none reached the national goal of 80%, but Montana was within 2 percentage points and six others had at least 70% viral suppression. This was an improvement over the 2013 viral suppression rates-only two jurisdictions out of 33 had at least 70% suppression [6] . When examining sub-populations, we found similar patterns of disparity across jurisdictions. In almost all jurisdictions whites had a higher rate of viral suppression then blacks or Hispanics/Latinos. There were only a few exceptions to this pattern and these were mostly in low-morbidity states where small yearto-year changes in numbers may result in large percent changes. The observation that viral suppression increases with age also held true in most jurisdictions. There were only two jurisdictions where viral suppression was higher among younger age groups than older. Further study of the jurisdictions that have high viral suppression among younger age groups may reveal particularly effective strategies that could be shared with other jurisdictions. In general, MSM had higher rates of viral suppression than PWID and those with infections attributed to heterosexual contact. One state with high viral suppression among PWID was Alaska. Determining factors that contributed to this outcome could help other jurisdictions attain similar results.
In addition to having a high level of viral suppression among all PLWDH, it is also important for people with newly diagnosed HIV to be promptly linked to care to attain viral suppression quickly to reduce their window of infectiousness as well as to improve their health outcomes. Among people who received a diagnosis in 2014, 68% were virally suppressed within 12 months. Six jurisdictions had at least 80% viral suppression among persons who received a diagnosis in 2014. These jurisdictions met the national goal for viral suppression among these persons [3] and may serve as models for best practices for attaining a high rate of viral suppression. Four of these jurisdictions also met the national goal of linking 85% of people receiving an HIV diagnosis in 2014 to care within 1 month of diagnosis [6] . Effective interventions that can help improve viral suppression rates include interventions to support linkage and retention in care, such as linkage coordination and case management [7] , and treatment adherence through support with mobile applications [8] . Public health departments and care providers can identify people who may be out of care and need re-engagement services or who are not virally suppressed and need treatment adherence counseling through surveillance or medical record data [9] . Ensuring all population segments have access to treatment as recommended will require addressing the challenges persons with HIV face with inadequate health insurance, comorbidities, mental health or substance misuse issues, or other social or economic disadvantages such as stigma or lack of transportation [10, 11] . This analysis is subject to at least the following limitations. First, we could only include 38 jurisdictions in the analysis, because complete lab reporting is necessary to accurately measure viral suppression rates. Therefore, the overall results may not be representative of all PLWDH in the United States and we could not evaluate disparities in viral suppression within all 50 states. However, the jurisdictions included in our analyses represent 72% of PLWDH and 71% of persons with HIV diagnosed in 2014 in the United States. Second, area of residence for viral suppression during 2014 among all PLWDH was based on most recent known address as of the end of 2014. If the most recent address in the surveillance data did not accurately reflect where an individual was living at the time, then they may be classified into the wrong jurisdiction.
These data highlight the need for tailored interventions at the local level. There are wide variations in the rate of viral suppression across jurisdictions as well as variations in disparity profiles, which suggests a one-size-fits-all approach will not be effective. However, there are opportunities for jurisdictions to learn from each other. Those jurisdictions who have relatively low viral suppression among particular groups could adapt effective interventions from similar jurisdictions with higher rates of viral suppression. Health care providers, state and local health departments, and community-based organizations can collaborate to develop effective interventions and the services and infrastructure needed to promote engagement in care and adherence to medication, which can lead to the desired outcome of viral suppression [12] . 
